53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.

Ghezraoui, Hind; Oliveira, Catarina; Becker, Jordan R; Bilham, Kirstin; Moralli, Daniela; Anzilotti, Consuelo; Fischer, Roman; Deobagkar-Lele, Mukta et al. · Nature · 2018

basic_science · Level V

Where this comes from

Abstract

53BP1 governs a specialized, context-specific branch of the classical non-homologous end joining DNA double-strand break repair pathway. Mice lacking 53bp1 (also known as Trp53bp1) are immunodeficient owing to a complete loss of immunoglobulin class-switch recombination<sup>1,2</sup>, and reduced fidelity of long-range V(D)J recombination<sup>3</sup>. The 53BP1-dependent pathway is also responsible for pathological joining events at dysfunctional telomeres<sup>4</sup>, and its unrestricted activity in Brca1-deficient cellular and tumour models causes genomic instability and oncogenesis<sup>5-7</sup>. Cells that lack core non-homologous end joining proteins are profoundly radiosensitive<sup>8</sup>, unlike 53BP1-deficient cells<sup>9,10</sup>, which suggests that 53BP1 and its co-factors act on specific DNA substrates. Here we show that 53BP1 cooperates with its downstream effector protein REV7 to promote non-homologous end joining during class-switch recombination, but REV7 is not required for 53BP1-dependent V(D)J recombination. We identify shieldin-a four-subunit putative single-stranded DNA-binding complex comprising REV7, c20orf196 (SHLD1), FAM35A (SHLD2) and FLJ26957 (SHLD3)-as the factor that explains this specificity. Shieldin is essential for REV7-dependent DNA end-protection and non-homologous end joining during class-switch recombination, and supports toxic non-homologous end joining in Brca1-deficient cells, yet is dispensable for REV7-dependent interstrand cross-link repair. The 53BP1 pathway therefore comprises distinct double-strand break repair activities within chromatin and single-stranded DNA compartments, which explains both the immunological differences between 53bp1- and Rev7- deficient mice and the context specificity of the pathway.

Medical subject headings